BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Cadrenal Therapeutics Inc. (NASDAQ:CVKD)

2 posts

Biotech NewsCadrenal (CVKD) Targeted at $30 After Acquiring Phase 2-Ready Frunexian

  • BioTech Health X
  • October 1, 2025
Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) is a clinical-stage biopharmaceutical company focused on addressing critical unmet needs in cardiovascular medicine,…
0 Shares
0
0
0
0
0
0
0

Biotech NewsWall Street Is Watching Cadrenal Therapeutics (CVKD)’s Next Move

  • BioTech Health X
  • August 14, 2025
Cadrenal Therapeutics Inc. (NASDAQ:CVKD) is a biopharmaceutical company dedicated to developing transformative therapeutics that address the significant limitations…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Addex Therapeutics (ADXN) Targets $330 Million Milestone Payouts
  • Arcadia Biosciences (RKDA) Surges 53%, But EBITDA Is Still -$5.9 Million
  • Bright Minds Biosciences (DRUG) Surges 158.8% in 12 Weeks
  • Vanda Pharmaceuticals (VNDA) Targets 300% Upside with Breakthrough FDA Framework Deal
  • Delcath (DCTH) Revenue Surges with 87% Gross Margin and Zero Debt Balance Sheet
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • October 19, 2025
    Addex Therapeutics (ADXN) Targets $330 Million Milestone Payouts
    • October 19, 2025
    Arcadia Biosciences (RKDA) Surges 53%, But EBITDA Is Still -$5.9 Million
    • October 19, 2025
    Bright Minds Biosciences (DRUG) Surges 158.8% in 12 Weeks
    • October 19, 2025
    Vanda Pharmaceuticals (VNDA) Targets 300% Upside with Breakthrough FDA Framework Deal
    • October 19, 2025
    Delcath (DCTH) Revenue Surges with 87% Gross Margin and Zero Debt Balance Sheet
Recent Posts
  • ResMed (RMD) Dominates $39.7 Billion Sleep Health Market
    • October 19, 2025
  • BioMarin (BMRN)’s Rare Disease Portfolio Generates Over $2.4 Billion in Annual Revenue
    • October 19, 2025
  • Edwards Lifesciences (EW) Set to Report $1.50B in Q3 Sales
    • October 19, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (484)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top